DENTSPLY Sirona Inc (NASDAQ:XRAY) price on current trading day, rose 1.83% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $14.15.
A look at the stock’s price movement, the level at last check in today’s session was $13.90, moving within a range at $13.895 and $14.195. The beta value (5-Year monthly) was 0.932. Turning to its 52-week performance, $30.78 and $12.16 were the 52-week high and 52-week low respectively. Overall, XRAY moved -3.38% over the past month.
DENTSPLY Sirona Inc’s market cap currently stands at around $2.82 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26. The company has a Forward Dividend ratio of 0.64, with its dividend yield at 4.52%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 853.91M for the company’s revenue for the quarter, with a low and high estimate of 830M and 873M respectively. The average forecast suggests down to a -10.40% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.57B, representing a -5.84% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that XRAY is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend XRAY as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
XRAY’s current price about 6.53% and -5.90% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.19, while 7-day volatility ratio is 3.14% and 5.22% in the 30-day chart. Further, DENTSPLY Sirona Inc (XRAY) has a beta value of 0.94, and an average true range (ATR) of 0.57. Analysts have given the company’s stock an average 52-week price target of $19, forecast between a low of $14 and high of $20. Looking at the price targets, the low is 1.06% off recent price level in today’s trading while to achieve the yearly target high, it has to move -41.34%. Nonetheless, investors will most likely welcome a -34.28% jump to $19 which is the analysts’ median price.
If we refocus on DENTSPLY Sirona Inc (NASDAQ:XRAY), historical trading data shows that trading volumes averaged 2.75 over the past 10 days and 3.06 million over the past 3 months. The company’s latest data on shares outstanding shows there are 198.80 million shares.
The 0.67% of DENTSPLY Sirona Inc’s shares are in the hands of company insiders while institutional holders own 102.44% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.87 million on 2025-04-15, giving us a short ratio of 3.06. The data shows that as of 2025-04-15 short interest in DENTSPLY Sirona Inc (XRAY) stood at 608.0 of shares outstanding, with shares short rising to 10.57 million registered in 2025-03-14. Current price change has pushed the stock -25.42% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the XRAY stock continues to rise going into the next quarter.
